参考文献/References:
[1] Schnall MD,Blume J,Bluemke DA,et al.Diagnostic architectural and dynamic features at breast MR imaging:multicenter study.Radiology,2006,238(1):42-53.
[2] Warren RM,Pointon L,Thompson D,et al.Reading protocol for dynamic contrast-enhanced MR images of the breast:sensitivity and specificity analysis.Radiology,2005,236(3):779-788.
[3] Onishi M,Furukawa A,Takahashi M,et al.A wide variety of Dynamic contrast-enhanced MR appearances of breast cancer:pathologic correlation study.Eur J Radiol,2008,65(2):286-292.
[4] Reddy JS,Mishra AM,Behari S,et al.The role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions:a report of 147 lesions.Surg Neurol,2006,66(3):246-250.
[5] Yabuuchi H,Kuroiwa T,Kusumoto C,et al.Incidentally detected lesions on contrast-enhanced MR imaging in candidates for breast-conserving therapy:correlation between MR fndings and histological diagnosis.J Magn Reson Imaging,2006,23(4):486-492.
[6] Siegmann KC,Krämer B,Claussen C.Current status and new developments in breast MRI.Breast Care(Basel),2011,6(2):87-92.
[7] Dorrius MD,Pijnappel RM,Jansen-van der Weide MC,et al.Determination of choline concentration in breast lesions:quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.Radiology,2011,259(3):695-703.
[8] Kuhl CK,Mielcareck P,Klaschik S,et al.Dynamic breast MR imaging:are signal intensity time course data useful for differential diagnosis of enhancing lesions.Radiology,1999,211(1):101-110.
[9] Sherif H,Mahfouz AE,Oellinger H,et al.Peripheral washout sign on contrast-enhanced MR images of the breast.Radiology,1997,205(1):209-213.
[10] Kinkel K,Helbich TH,Esserman LJ,et al.Dynamic high-spatial-resolution MR imaging of suspicious breast lesions:diagnostic criteria and interobserver variability.AJR Am J Roentgenol,2000,175(1):35-43.
[11] Moon M,Comfeld D,Weinreb J.Dynamic contrast-enhanced breast MR imaging.Magn Reson Imaging Clin N Am,2009,17(2):351-362.
[12] Shafqat G,Agha A,Masror I,et al.Dynamic contrast enhanced MRI breast for lesion detection and characterization with histopathological co relation:preliminary experience at tertiary care hospital.J Pak Med Assoc,2011,61(3):252-255.
[13] Goto M,Ito H,Akazawa K,et al.Diagnosis of breast tumors by contrast-enhanced MR imaging:comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.J Magn Reson Imaging,2007,25(1):104-112.
[14] Jansen SA,Newstead GM,Abe H,et al.Pure ductal carcinoma in situ:kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.Radiology,2007,245(3):684-691.
[15] Isomoto I,Koshiishi T,Okimoto T,et al.Gradually enhancing breast cancer on dynamic MRI.Nihon Igaku Hoshasen Gakkai Zasshi,2000,60(9):514-519.
[16] Yabuuchi H,Matsuo Y,Okafuji T,et al.Enhanced mass on contrast-enhanced breast MR imaging:Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.J Magn Reson Imaging,2008,28(5):1157-1165.
[17] Marini C,Iacconi C,Giannelli M,et al.Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion.Eur Radiol,2007,17(10):2646-2655.
[18] Park MJ,Cha ES,Kang BJ,et al.The role of diffusion-weighted imaging and the apparent diffusion coefficient(ADC) values for breast tumors.Korean J Radiol,2007,8(5):390-396.
[19] Paran Y,Bendel P,Margalit R,et al.Water diffusion in the different microenvironments of breast cancer.NMR Biomed,2004,17(4):170-180.
[20] Yoshikawa MI,Ohsumi S,Sugata S,et al.Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer.Radiat Med,2008,26(4):222-226.
[21] Manenti G,Di Roma M,Mancino S,et al.Malignant renal neoplasms:correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T.Radiol Med,2008,113(2):199-213.
[22] Matsumoto Y,Kuroda M,Matsuya R,et al.In vitro experimental study of the relationship between the apparent diffusion coefficient and changes in cellularity and cell morphology.Oncol Rep,2009,22(3):641-648.
[23] Jenkinson MD,du Plessis DG,Smith TS,et al.Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype.J Neurooncol,2010,96(3):385-392.
[24] Englander SA,Ulu AM,Brem R,et al.Diffusion imaging of human breast.NMR Biomed,1997,10(7):348-352.
[25] Kul S,Cansu A,Alhan E,et al.Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.AJR Am J Roentgenol,2011,196(1):210-217.
[26] Woodhams R,Matsunaga K,Iwabuchi K,et al.Diffusion-weighted imaging of malignant breast tumors:the usefulness of apparent diffusion coefficient(ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension.J Comput Assist Tomogr,2005,29(5):644-649.
[27] Costantini M,Belli P,Rinaldi P,et al.Diffusion-weighted imaging in breast cancer:relationship between apparent diffusion coefficient and tumour aggressiveness.Clin Radiol,2010,65(12):1005-1012.
[28] Yamada K,Kubota H,Kizu O,et al.Effect of intravenous gadolinium-DTPA on diffusion-weighted images:evaluation of normal brain and infarcts.Stroke,2002,33(7):1799-1802.
[29] Firat AK,Sanli B,Karakas HM,et al.The effect of intravenous gadolinium-DTPA on diffusion-weighted imaging.Neuroradiology,2006,48(7):465-470.
[30] Yuen S,Yamada K,Goto M,et al.Microperfusion-induced elevation of ADC is suppressed after contrast in breast carcinoma.J Magn Reson Imaging,2009,29(5):1080-1084.
[31] Kuroki Y,Nasu K.Advances in breast MRI:diffusion-weighted imaging of the breast.Breast Cancer,2008,15(3):212-217.
[32] Kvistad KA,Rydland J,Vainio J,et al.Breast lesions:evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.Radiology,2000,216(2):545-553.
[33] Buteau-Lozano H,Velasco G,Cristofari M,et al.Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.J Endocrinol,2008,196(2):399-412.
[34] Liu Y,Tamimi RM,Collins LC,et al.The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy:results from the Nurses’ Health Study.Breast Cancer Res Treat,2011,129(1):175-184.
[35] Zhuang XM,Zhang B,Zhu B,et al.Application of T2*-weighted first-pass perfusion imaging in the diagnosis of breast tumors.Chin Ger J Clin Oncol,2007,6(4):357-360,
[36] Ferrier MC,Sarin H,Fung SH,et al.Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.Neoplasia,2007,9(7):546-555.
[37] Zhu DC,Buonocore MH.Breast tissue differentiation using arterial spin tagging.Magn Reson Med,2003,50(5):966-975.
[38] Iacconi C.Diffusion and perfusion of the breast.Eur J Radiol,2010,76(3):386-390.
[39] Tozaki M,Fukuda Y,Fukuda K.Multi-section magnetic susceptibility perfusion echo-planar imaging of the breast.Nihon Igaku Hoshasen Gakkai Zasshi,2003,63(5):214-220.
[40] Delille JP,Slanetz PJ,Yeh ED,et al.Hormone replacement therapy in postmenopausal women:breast tissue perfusion determined with MR imaging-initial observations.Radiology,2005,235(1):36-41.
[41] Makkat S,Luypaert R,Sourbron S,et al.Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus TJ-DCE data.J Magn Reson Imaging,2007,25(6):1159-1167.
[42] Sardanelli F,Fausto A,Podo F.MR spectroscopy of the breast.Radiol Med,2008,113(1):56-64.
[43] Sitter B,Bathen TF,Singstad TE,et al.Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy.NMR Biomed,2010,23(4):424-431.
[44] Tse GM,Cheung HS,Pang LM,et al.Characterization of lesions of the breast with proton MR spectroscopy:comparison of carcinomas,benign lesions,and phyllodes tumors.AJR Am J Roentgenol,2003,181(5):1267-1272.
[45] Huang W,Fisher PR,Dulaimy K,et al.Detection of breast malignancy:diagnostic MR protocol for improved specificity.Radiology,2004,232(2):585-591.
[46] Bartella L,Morris EA,Dershaw DD,et al.Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis:preliminary study.Radiology,2006,239(3):686-692.
[47] Stanwell P,Mountford C.In vivo proton MR spectroscopy of the breast.Radiographics,2007,27 Suppl 1:S253-266.
[48] Tse GM,Yeung DK,King AD,et al.In vivo proton magnetic resonance spectroscopy of breast lesions:an update.Breast Cancer ResTreat,2007,104(3):249-255.
[49] Tozaki M.Proton MR spectroscopy of the breast.Breast Cancer,2008,15(3):218-223.
[50] Bartella L,Huang W.Proton(1H) MR spectroscopy of the breast.Radiographics.2007,27 Suppl 1:S241-252.
[51] Tozaki M,Fukuma E.1H MR spectroscopy and diffusion-weighted imaging of the breast:are they useful tools for characterizing breast lesions before biopsy?.AJR Am J Roentgenol,2009,193(3):840-849.
[52] Stanwell P,Gluch L,Clark D,et al.Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.Eur Radiol,2005,15(5):1037-1043.
[53] Glunde K,Jie C,Bhujwaila ZM.Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.Cancer Res,2004,64(12):4270-4276.
[54] Bolan PJ,Meisamy S,Baker EH,et al.In vivo quantification of choline compounds in the breast with 1H MR spectroscopy.Magn Reson Med,2003,50(6):1134-1143.
[55] Yeung DK,Yang WT,Tse GM.Breast cancer:in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.Radiology,2002,225(1):190-197.
[56] Seenu V,Pavan Kumar MN,Sharma U,et al.Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer.Magn Reson Imaging,2005,23(10):1005-1010.
[57] Jagannathan NR,Kumar M,Seenu V,et al.Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.Br J Cancer,2001,84(8):1016-1022.
[58] Meisamy S,Bolan PJ,Baker EH,et al.Neoadjuvant chemotherapy of locally advanced breast cancer:predicting response with in vivo (1)H MR spectroscopy-a pilot study at 4 T.Radiology,2004,233(2):424-431.
[59] Nelson MT,Everson LI,Garwood M,et al.MR Spectroscopy in the diagnosis and treatment of breast cancer.Semin Breast Dis,2008,11(2):100-105.
[60] Tozaki M,Sakamoto M,Oyama Y,et al.Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method.J Magn Reson Imaging,2010,31(4):895-902.
[61] Tafreshi NK,Kumar Y,Morse DL,et al.Molecular and functional imaging of breast cancer.Cancer Control,2010,17(3):143-155.
[62] Jacobs MA,Barker PB,Argani P,et al.Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging:a feasibility study.J Magn Reson Imaging,2005,21(1):23-28.
[63] Hirose M,Nobusawa H,Gokan T.MR ductography:comparison with conventional ductography as a diagnostic method in patients with nipple discharge.Radiographics,2007,Suppl 1:S183-196.
[64] Rovno HD,Siegelman ES,Reynolds C,et al.Solitary intraductal papilloma:findings at MR imaging and MR galactography.AJR Am J Roentgenol,1999,172(1):151-155.
[65] Kanemaki Y,Kurihara Y,Itoh D,et al.MR mammary ductography using a microscopy coil for assessment of intraductal lesions.AJR Am J Roentgenol,2004,182(5):1340-1342.
[66] Bhattarai N,Kanemaki Y,Kurihara Y,et al.Intraductal papilloma:features on MR ductography using a microscopic coil.AJR Am J Roentgenol,2006,186(1):44-47.
相似文献/References:
[1]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[2]蒿崑,孙珊珊,赵斌.规范化应用影像学检查对乳腺疾病诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(1):70.[doi:10.3760/cma.j.issn.1673-4114.2016.01.014]
Hao Kun,Sun Shanshan,Zhao Bin.The value of the standard application of medical imaging examination in the diagnosis of breast disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):70.[doi:10.3760/cma.j.issn.1673-4114.2016.01.014]
[3]李敏,蒋涛,彭朋,等.直肠内注入模拟粪便的动态MRI对女性盆底痉挛综合征的诊断价值[J].国际放射医学核医学杂志,2016,40(3):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
Li Min,Jiang Tao,Peng Peng,et al.Value of dynamic MRI with rectum injection in the diagnosis of female spastic pelvic floor syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):165.[doi:10.3760/cma.j.issn.1673-4114.2016.03.001]
[4]唐令胜,刘朝晖,李红梅,等.低场磁共振DWI技术与常规MRI扫描对超急性脑梗死的诊断灵敏度的比较[J].国际放射医学核医学杂志,2016,40(3):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
Tang Lingsheng,Liu Zhaohui,Li Hongmei,et al.Comparison of the diagnostic sensitivity of low-field magnetic resonance diffusion weighted imaging technology and conventional MRI scanning for super acute cerebral infarction[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):187.[doi:10.3760/cma.j.issn.1673-4114.2016.03.006]
[5]贺小红,周新韩,高明勇,等.模型模拟修改部分扫描参数加速MR扫描的方法可行性探讨[J].国际放射医学核医学杂志,2016,40(4):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
He Xiaohong,Zhou Xinhan,Gao Mingyong,et al.Feasibility of accelerating MR scan by modifying part of scanning parameters：a phantom simulation study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):267.[doi:10.3760/cma.j.issn.1673-4114.2016.04.006]
[6]龙再颖,赵燕霞,孙达.乳腺神经内分泌癌99Tcm-MIBI显像表现一例[J].国际放射医学核医学杂志,2016,40(4):318.[doi:10.3760/cma.j.issn.1673-4114.2016.04.016]
[7]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]周金鑫,张一帆.胰岛细胞移植监测的分子影像学进展[J].国际放射医学核医学杂志,2015,39(6):478.[doi:10.3760/cma.j.issn.1673-4114.2015.06.009]
Zhou Jinxin,Zhang Yifan.Research progress of molecular imaging in monitoring islet transplantation[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):478.[doi:10.3760/cma.j.issn.1673-4114.2015.06.009]
[10]樊鹏,甄俊平,王峻.MR示踪技术在干细胞移植治疗软骨缺损中的研究进展[J].国际放射医学核医学杂志,2015,39(6):497.[doi:10.3760/cma.j.issn.1673-4114.2015.06.013]
Fan Peng,Zhen Junping,Wang Jun.The progress of magnetic resonance cell tracing technique in stem cells transplantation treatment of cartilage defects[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):497.[doi:10.3760/cma.j.issn.1673-4114.2015.06.013]
[11]卢瑞梁,贺小红,蔡华清,等.不同MRI序列检出聚丙烯酰胺水凝胶注射隆乳患者乳腺病变效能的比较研究[J].国际放射医学核医学杂志,2016,40(6):435.[doi:10.3760/cma.j.issn.1673-4114.2016.06.007]
Lu Ruiliang,He Xiaohong,Cai Huaqing,et al.The different MRI sequences to detect breast lesions in polyacrylamide hydrogel injection for augmentation patients: a comparative study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):435.[doi:10.3760/cma.j.issn.1673-4114.2016.06.007]